Research shows that when cancer metastasizes, tumor cells can escape from the primary tumor and enter the patient's peripheral blood to form so-called circulating tumor cells (CTCs). When they metastasize to the stromal microenvironment formed by appropriate organs or tissues, new tumors may form. The tumor cells released when solid tumors or lesions metastasize are an important cause of postoperative recurrence and distant metastasis in patients with malignant tumors, and are also an important factor leading to the death of tumor patients. Currently, they have been confirmed by research to include breast cancer and lung cancer. Diagnostic and prognostic markers for various cancers, including pancreatic cancer, colorectal cancer, etc. Therefore, if circulating tumor cells can be quickly detected in the blood and their number, type and characteristics can be assessed, it will help monitor tumor recurrence, evaluate drug efficacy, assist treatment decisions and adjust treatment plans, and provide better treatment for patients. Treatment and Care.
The global Circulating Tumor Cell Detection System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Circulating Tumor Cell Detection System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Circulating Tumor Cell Detection System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Circulating Tumor Cell Detection System include Watson Biotech, Epione Med, RareCyte, Bio-Rad, Wuhan Youzhiyou Medical Technology, Meijing Medical, BGI, Watson Bio and Rarecells, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cell Detection System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cell Detection System.
Report Scope
The Circulating Tumor Cell Detection System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Tumor Cell Detection System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cell Detection System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Watson Biotech
Epione Med
RareCyte
Bio-Rad
Wuhan Youzhiyou Medical Technology
Meijing Medical
BGI
Watson Bio
Rarecells
ANGLE plc
Miltenyi Biotec
Menarini Silicon Biosystems
Segment by Type
Detection Kit
Testing Equipment
Segment by Application
Clinical Application
Scientific Research
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Circulating Tumor Cell Detection System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Circulating Tumor Cell Detection System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Circulating Tumor Cell Detection System Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cell Detection System
1.2 Circulating Tumor Cell Detection System Segment by Type
1.2.1 Global Circulating Tumor Cell Detection System Market Value Comparison by Type (2024-2030)
1.2.2 Detection Kit
1.2.3 Testing Equipment
1.3 Circulating Tumor Cell Detection System Segment by Application
1.3.1 Global Circulating Tumor Cell Detection System Market Value by Application: (2024-2030)
1.3.2 Clinical Application
1.3.3 Scientific Research
1.4 Global Circulating Tumor Cell Detection System Market Size Estimates and Forecasts
1.4.1 Global Circulating Tumor Cell Detection System Revenue 2019-2030
1.4.2 Global Circulating Tumor Cell Detection System Sales 2019-2030
1.4.3 Global Circulating Tumor Cell Detection System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Circulating Tumor Cell Detection System Market Competition by Manufacturers
2.1 Global Circulating Tumor Cell Detection System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Circulating Tumor Cell Detection System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Circulating Tumor Cell Detection System Average Price by Manufacturers (2019-2024)
2.4 Global Circulating Tumor Cell Detection System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Circulating Tumor Cell Detection System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Circulating Tumor Cell Detection System, Product Type & Application
2.7 Circulating Tumor Cell Detection System Market Competitive Situation and Trends
2.7.1 Circulating Tumor Cell Detection System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Circulating Tumor Cell Detection System Players Market Share by Revenue
2.7.3 Global Circulating Tumor Cell Detection System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Circulating Tumor Cell Detection System Retrospective Market Scenario by Region
3.1 Global Circulating Tumor Cell Detection System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Circulating Tumor Cell Detection System Global Circulating Tumor Cell Detection System Sales by Region: 2019-2030
3.2.1 Global Circulating Tumor Cell Detection System Sales by Region: 2019-2024
3.2.2 Global Circulating Tumor Cell Detection System Sales by Region: 2025-2030
3.3 Global Circulating Tumor Cell Detection System Global Circulating Tumor Cell Detection System Revenue by Region: 2019-2030
3.3.1 Global Circulating Tumor Cell Detection System Revenue by Region: 2019-2024
3.3.2 Global Circulating Tumor Cell Detection System Revenue by Region: 2025-2030
3.4 North America Circulating Tumor Cell Detection System Market Facts & Figures by Country
3.4.1 North America Circulating Tumor Cell Detection System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Circulating Tumor Cell Detection System Sales by Country (2019-2030)
3.4.3 North America Circulating Tumor Cell Detection System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Circulating Tumor Cell Detection System Market Facts & Figures by Country
3.5.1 Europe Circulating Tumor Cell Detection System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Circulating Tumor Cell Detection System Sales by Country (2019-2030)
3.5.3 Europe Circulating Tumor Cell Detection System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Circulating Tumor Cell Detection System Market Facts & Figures by Country
3.6.1 Asia Pacific Circulating Tumor Cell Detection System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Circulating Tumor Cell Detection System Sales by Country (2019-2030)
3.6.3 Asia Pacific Circulating Tumor Cell Detection System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Circulating Tumor Cell Detection System Market Facts & Figures by Country
3.7.1 Latin America Circulating Tumor Cell Detection System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Circulating Tumor Cell Detection System Sales by Country (2019-2030)
3.7.3 Latin America Circulating Tumor Cell Detection System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Circulating Tumor Cell Detection System Market Facts & Figures by Country
3.8.1 Middle East and Africa Circulating Tumor Cell Detection System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Circulating Tumor Cell Detection System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Circulating Tumor Cell Detection System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Circulating Tumor Cell Detection System Sales by Type (2019-2030)
4.1.1 Global Circulating Tumor Cell Detection System Sales by Type (2019-2024)
4.1.2 Global Circulating Tumor Cell Detection System Sales by Type (2025-2030)
4.1.3 Global Circulating Tumor Cell Detection System Sales Market Share by Type (2019-2030)
4.2 Global Circulating Tumor Cell Detection System Revenue by Type (2019-2030)
4.2.1 Global Circulating Tumor Cell Detection System Revenue by Type (2019-2024)
4.2.2 Global Circulating Tumor Cell Detection System Revenue by Type (2025-2030)
4.2.3 Global Circulating Tumor Cell Detection System Revenue Market Share by Type (2019-2030)
4.3 Global Circulating Tumor Cell Detection System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Circulating Tumor Cell Detection System Sales by Application (2019-2030)
5.1.1 Global Circulating Tumor Cell Detection System Sales by Application (2019-2024)
5.1.2 Global Circulating Tumor Cell Detection System Sales by Application (2025-2030)
5.1.3 Global Circulating Tumor Cell Detection System Sales Market Share by Application (2019-2030)
5.2 Global Circulating Tumor Cell Detection System Revenue by Application (2019-2030)
5.2.1 Global Circulating Tumor Cell Detection System Revenue by Application (2019-2024)
5.2.2 Global Circulating Tumor Cell Detection System Revenue by Application (2025-2030)
5.2.3 Global Circulating Tumor Cell Detection System Revenue Market Share by Application (2019-2030)
5.3 Global Circulating Tumor Cell Detection System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Watson Biotech
6.1.1 Watson Biotech Corporation Information
6.1.2 Watson Biotech Description and Business Overview
6.1.3 Watson Biotech Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Watson Biotech Circulating Tumor Cell Detection System Product Portfolio
6.1.5 Watson Biotech Recent Developments/Updates
6.2 Epione Med
6.2.1 Epione Med Corporation Information
6.2.2 Epione Med Description and Business Overview
6.2.3 Epione Med Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Epione Med Circulating Tumor Cell Detection System Product Portfolio
6.2.5 Epione Med Recent Developments/Updates
6.3 RareCyte
6.3.1 RareCyte Corporation Information
6.3.2 RareCyte Description and Business Overview
6.3.3 RareCyte Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 RareCyte Circulating Tumor Cell Detection System Product Portfolio
6.3.5 RareCyte Recent Developments/Updates
6.4 Bio-Rad
6.4.1 Bio-Rad Corporation Information
6.4.2 Bio-Rad Description and Business Overview
6.4.3 Bio-Rad Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio-Rad Circulating Tumor Cell Detection System Product Portfolio
6.4.5 Bio-Rad Recent Developments/Updates
6.5 Wuhan Youzhiyou Medical Technology
6.5.1 Wuhan Youzhiyou Medical Technology Corporation Information
6.5.2 Wuhan Youzhiyou Medical Technology Description and Business Overview
6.5.3 Wuhan Youzhiyou Medical Technology Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wuhan Youzhiyou Medical Technology Circulating Tumor Cell Detection System Product Portfolio
6.5.5 Wuhan Youzhiyou Medical Technology Recent Developments/Updates
6.6 Meijing Medical
6.6.1 Meijing Medical Corporation Information
6.6.2 Meijing Medical Description and Business Overview
6.6.3 Meijing Medical Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Meijing Medical Circulating Tumor Cell Detection System Product Portfolio
6.6.5 Meijing Medical Recent Developments/Updates
6.7 BGI
6.6.1 BGI Corporation Information
6.6.2 BGI Description and Business Overview
6.6.3 BGI Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BGI Circulating Tumor Cell Detection System Product Portfolio
6.7.5 BGI Recent Developments/Updates
6.8 Watson Bio
6.8.1 Watson Bio Corporation Information
6.8.2 Watson Bio Description and Business Overview
6.8.3 Watson Bio Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Watson Bio Circulating Tumor Cell Detection System Product Portfolio
6.8.5 Watson Bio Recent Developments/Updates
6.9 Rarecells
6.9.1 Rarecells Corporation Information
6.9.2 Rarecells Description and Business Overview
6.9.3 Rarecells Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Rarecells Circulating Tumor Cell Detection System Product Portfolio
6.9.5 Rarecells Recent Developments/Updates
6.10 ANGLE plc
6.10.1 ANGLE plc Corporation Information
6.10.2 ANGLE plc Description and Business Overview
6.10.3 ANGLE plc Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 ANGLE plc Circulating Tumor Cell Detection System Product Portfolio
6.10.5 ANGLE plc Recent Developments/Updates
6.11 Miltenyi Biotec
6.11.1 Miltenyi Biotec Corporation Information
6.11.2 Miltenyi Biotec Circulating Tumor Cell Detection System Description and Business Overview
6.11.3 Miltenyi Biotec Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Miltenyi Biotec Circulating Tumor Cell Detection System Product Portfolio
6.11.5 Miltenyi Biotec Recent Developments/Updates
6.12 Menarini Silicon Biosystems
6.12.1 Menarini Silicon Biosystems Corporation Information
6.12.2 Menarini Silicon Biosystems Circulating Tumor Cell Detection System Description and Business Overview
6.12.3 Menarini Silicon Biosystems Circulating Tumor Cell Detection System Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Menarini Silicon Biosystems Circulating Tumor Cell Detection System Product Portfolio
6.12.5 Menarini Silicon Biosystems Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Circulating Tumor Cell Detection System Industry Chain Analysis
7.2 Circulating Tumor Cell Detection System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Circulating Tumor Cell Detection System Production Mode & Process
7.4 Circulating Tumor Cell Detection System Sales and Marketing
7.4.1 Circulating Tumor Cell Detection System Sales Channels
7.4.2 Circulating Tumor Cell Detection System Distributors
7.5 Circulating Tumor Cell Detection System Customers
8 Circulating Tumor Cell Detection System Market Dynamics
8.1 Circulating Tumor Cell Detection System Industry Trends
8.2 Circulating Tumor Cell Detection System Market Drivers
8.3 Circulating Tumor Cell Detection System Market Challenges
8.4 Circulating Tumor Cell Detection System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Watson Biotech
Epione Med
RareCyte
Bio-Rad
Wuhan Youzhiyou Medical Technology
Meijing Medical
BGI
Watson Bio
Rarecells
ANGLE plc
Miltenyi Biotec
Menarini Silicon Biosystems
听
听
*If Applicable.
